Condition: Oral Mucositis · Sponsor: Peter MacCallum Cancer Centre, Australia
The goal of this study is to describe the effect of photobiomodulation (PBM) on the incidence and severity of oral mucositis in post-operative oral cancer patients receiving radiotherapy +/- chemotherapy. Participants will receive PBM treatment five times a week throughout the course of their radiotherapy. The main question it aims to answer is whether photobiomodulation reduces the incidence and severity of oral mucositis.
This description comes directly from the study's public registry record.
Sophie Beaumont, Bachelor of Dental surgery · 03 85596443 · sophie.beaumont@petermac.org
Shae Beaton, Bachelor of oral health · 03 85596443 · shae.beaton@petermac.org
Always discuss trial participation with your own doctor first.
| Peter MacCallum Cancer Centre | Melbourne, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07387978